Stage-based implementation of Immediate Postpartum Long Acting Reversible Contraception Using a Reproductive Justice Framework.

07:00 EST 30th November 2019 | BioPortfolio

Summary of "Stage-based implementation of Immediate Postpartum Long Acting Reversible Contraception Using a Reproductive Justice Framework."

The immediate postpartum period (IPP) is a favorable, safe and effective time to provide long acting reversible contraceptives (LARC), yet it is not widely available. We describe an innovative hospital-based approach to IPP LARC that includes: 1) an emphasis on multidisciplinary teambuilding and identification of champions; 2) focus on using implementation science at every stage of the process to develop a systematic and replicable strategy; and, 3) an imperative to apply a reproductive justice framework to IPP LARC implementation. Our model was developed using implementation science best practices. Implementation teams comprised of diverse stakeholders were formed, which included champions to promote progress. Our team assessed the implementation context for IPP LARC and used the findings to develop a readiness assessment for hospitals. A stage-based implementation checklist was then developed to outline necessary infrastructure to support an IPP LARC initiative. A reproductive justice lens guided planning and implementation. The three innovative aspects of our implementation process resulted in a systematic, multidisciplinary and culturally appropriate model for IPP LARC that can be replicated across hospitals. Implementation teams and champions moved the work forward at each hospital, and three of the five participating hospitals moved beyond the exploration stage of implementation during the engagement. Patient education materials and provider trainings incorporated person-centered and reproductive justice frameworks. Our hope is to continue to partner with stakeholders to better understand how our efforts to support hospital provision of IPP LARC can increase reproductive health equity rather than perpetuate disparity.


Journal Details

This article was published in the following journal.

Name: American journal of obstetrics and gynecology
ISSN: 1097-6868


DeepDyve research library

Clinical Trials [14060 Associated Clinical Trials listed on BioPortfolio]

Feasibility of Immediate Postpartum Long-acting Reversible Contraception Implementation

The objective of this study is to test and disseminate tools that drive successful immediate postpartum Long-Acting Reversible Contraception (LARC) implementation. The long-term goal is to...

Evaluation of Immediate Postpartum LARC Implementation Programs

This study will engage hospitals working with the New Mexico Perinatal Collaborative (NMPC) on implementing immediate postpartum long-acting reversible contraception programs. All hospital...

Patient Compliance With Long-Acting Reversible Contraception Administration

This a randomized control trial to identify if patients who desire LARC are more likely to have success receiving the desired form of contraception if it is placed a) during the postpartum...

Home-based Delivery of the Contraceptive Implant in Postpartum Guatemalan Women

Abstract Background: Postpartum contraception is important to prevent unintended and closely spaced pregnancies following childbirth. Methods: This study is a cluster-randomized tr...

A Comparison of Short Interval vs. Routine Postpartum Visit on Contraceptive Initiation

The current postpartum care model of a single visit 4-6 weeks after delivery does not optimally address contraceptive needs. By this visit, many women have resumed sexual activity, potenti...

Medical and Biotech [MESH] Definitions

Prevention of CONCEPTION by devices, chemical substances or agents with contraceptive activity in females which last for years and can be removed.

An insulin preparation that is designed to provide immediate and long term glycemic control in a single dosage. Biphasic insulin typically contains a mixture of REGULAR INSULIN or SHORT-ACTING INSULIN combined with a LONG-ACTING INSULIN.

Transient autoimmune thyroiditis occurring in the POSTPARTUM PERIOD. It is characterized by the presence of high titers of AUTOANTIBODIES against THYROID PEROXIDASE and THYROGLOBULIN. Clinical signs include the triphasic thyroid hormone pattern: beginning with THYROTOXICOSIS, followed with HYPOTHYROIDISM, then return to euthyroid state by 1 year postpartum.

One of the long-acting ANTIPSYCHOTIC AGENTS used for maintenance or long-term therapy of SCHIZOPHRENIA and other PSYCHOTIC DISORDERS.

Excess blood loss from uterine bleeding associated with OBSTETRIC LABOR or CHILDBIRTH. It is defined as blood loss greater than 500 ml or of the amount that adversely affects the maternal physiology, such as BLOOD PRESSURE and HEMATOCRIT. Postpartum hemorrhage is divided into two categories, immediate (within first 24 hours after birth) or delayed (after 24 hours postpartum).

Quick Search

DeepDyve research library

Relevant Topic

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Searches Linking to this Article